Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-12-11
1987-10-06
Jiles, Henry R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 83, 546164, A61K 3141, C07D49804, C07D21520
Patent
active
046983473
ABSTRACT:
Trans-(.+-.)-2- and/or -5-permissibly substituted octahydro-oxazolo[4,5-g]quinolines, acid addition salts thereof and individual enantiomers thereof, useful as dopamine agonists or intermediates of the preparation of dopamine agonists.
REFERENCES:
patent: 4230861 (1980-10-01), Kornfeld et al.
March, Advanced Organic Chemistry, 2nd Ed., 1977, pp. 381-383, 477-478, 1127, 658-659.
Newkome and Puadler, Contemporary Heterocyclic Chemistry, (1982), pp. 37-38.
Organic Reactions (Eds. Roger Adams et al.), vol. 10, p. 148.
Schaus John M.
Titus Robert D.
Ashbrook Charles W.
Eli Lilly and Company
Jiles Henry R.
Richter J.
Whitaker Leroy
LandOfFree
Octahydro-oxazolo[4,5-g]quinolines derivatives and decahydro qui does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Octahydro-oxazolo[4,5-g]quinolines derivatives and decahydro qui, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Octahydro-oxazolo[4,5-g]quinolines derivatives and decahydro qui will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2117525